|
Market Closed -
Bombay S.E.
06:02:26 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 84.05 INR | +2.06% |
|
+0.49% | -43.34% |
| 10-18 | Camlin Fine Sciences Limited Announces Cessation of Pradip Kanakia as Independent Director, Effective October 18, 2026 | CI |
| 08-11 | Camlin Fine Sciences Limited, Q1 2027 Earnings Call, Aug 11, 2026 |
Company Valuation: Camlin Fine Sciences Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 21,899 | 20,006 | 14,946 | 31,552 | 18,623 | 16,145 | - |
| Change | - | -8.65% | -25.29% | 111.1% | -40.98% | -13.3% | - |
| Enterprise Value (EV) | 21,899 | 20,006 | 14,946 | 31,552 | 18,623 | 16,145 | 16,145 |
| Change | - | -8.65% | -25.29% | 111.1% | -40.98% | -13.3% | 0% |
| P/E | 30.6x | 37.3x | -16x | -20.9x | 67.3x | 21x | 10.4x |
| PBR | - | 2.44x | 1.73x | - | 1.86x | 1.44x | 1.26x |
| PEG | - | -1.5x | 0x | -0.5x | -1x | 0x | 0x |
| Capitalization / Revenue | 1.55x | 1.19x | 0.93x | - | 1.08x | 0.76x | 0.66x |
| EV / Revenue | 0x | 0x | 0x | - | 0x | 0.76x | 0.66x |
| EV / EBITDA | 0x | 0x | 0x | - | 0x | 6.41x | 4.42x |
| EV / EBIT | 0x | 0x | -0x | - | 0x | 9.35x | 5.69x |
| EV / FCF | -0x | -0x | 0x | -0x | 0x | 197x | 8.32x |
| FCF Yield | -3.12% | -4.67% | 5.25% | -0.5% | 1.32% | 0.51% | 12% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | 4.56 | 3.41 | -5.58 | -8.03 | 1.44 | 4 | 8.1 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 14,121 | 16,816 | 16,131 | - | 17,233 | 21,331 | 24,351 |
| EBITDA 1 | 1,528 | 2,053 | 739.2 | - | 1,069 | 2,517 | 3,653 |
| EBIT 1 | 968.4 | 1,428 | -46.91 | - | 359.6 | 1,726 | 2,836 |
| Net income 1 | 606.8 | 521.1 | -927.5 | - | 276.3 | 765 | 1,555 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 139.50 | 127.35 | 89.25 | 167.90 | 96.95 | 84.05 | 84.05 |
| Nbr of stocks (in thousands) | 156,984 | 157,093 | 167,465 | 187,921 | 192,087 | 192,092 | - |
| Announcement Date | 5/19/22 | 5/22/23 | 5/20/24 | 5/23/25 | 5/26/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 20.59x | - | - | - | 166M | ||
| 39.81x | 5.37x | 21.86x | 0.97% | 84.34B | ||
| 33.9x | 5.12x | 21.9x | 1.89% | 43.75B | ||
| 24.23x | 2.87x | 15.02x | 2.16% | 34.63B | ||
| 15.4x | 1.6x | 8.95x | 2.72% | 33.66B | ||
| 39.5x | 7.1x | 18.82x | 1.57% | 32.38B | ||
| 14.82x | 1.41x | 8.73x | 2.15% | 26.34B | ||
| 39.37x | 9.54x | 29.25x | 2.26% | 23.89B | ||
| 26.39x | 2.84x | 11.55x | 1.7% | 18.98B | ||
| 7.64x | 2.16x | 4.3x | 3.43% | 16.1B | ||
| Average | 26.17x | 4.22x | 15.60x | 2.09% | 31.42B | |
| Weighted average by Cap. | 30.03x | 4.50x | 17.35x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CAMLINFINE Stock
- Valuation Camlin Fine Sciences Limited
Select your edition
All financial news and data tailored to specific country editions
















